Mécanisme action And NotJ. I. Fletcher

List of bibliographic references

Number of relevant bibliographic references: 30.

Ident.	Authors (with country if any)	Title
000B81	César Mattei [France] ; Frédéric Meunier [Australie]	Toxines botuliques: poison et médicament
000E80	Delphine B. Maurel [France] ; Stephane Pallu [France] ; Christelle Jaffre [France] ; Nicola L. Fazzalari [France, Australie] ; Nathalie Boisseau [France] ; Rustem Uzbekov [France] ; Claude-Laurent Benhamou [France] ; Gael Y. Rochefort [France]	Osteocyte Apoptosis and Lipid Infiltration as Mechanisms of Alcohol-Induced Bone Loss
001C76	MICHELLE HONG [Singapour] ; Anne-Laure Puaux [Singapour] ; Caleb Huang [Singapour] ; Laure Loumagne [Singapour] ; Charlene Tow [Singapour] ; Charles Mackay [Australie] ; Masashi Kato [Japon] ; Armelle Prevost-Blondel [France] ; Marie-Françoise Avril [France] ; Alessandra Nardin [Singapour] ; Jean-Pierre Abastado [Singapour]	Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control
001E00	C. Underhill [France, Australie] ; M. Toulmonde [France] ; H. Bonnefoi [France]	A review of PARP inhibitors: from bench to bedside
002563	Truong D. Nguyen-Huu [Australie] ; César Mattei [France] ; Peter J. Wen [Australie] ; Andrea J. Bourdelais [États-Unis] ; Richard J. Lewis [Australie] ; Evelyne Benoit [France] ; Daniel G. Baden [États-Unis] ; Jordi Molgo [France] ; Frédéric A. Meunier [Australie]	Ciguatoxin-induced catecholamine secretion in bovine chromaffin cells: Mechanism of action and reversible inhibition by brevenal
002D99	Hai-Tao Zhao [Australie] ; Isabelle Hazemann [France] ; Andre Mitschler [France] ; Vincenzo Carbone [Australie] ; Andrzej Joachimiak [États-Unis] ; Steve Ginell [États-Unis] ; Alberto Podjamy [France] ; Ossama El-Kabbani [Australie]	Unusual Binding Mode of the 2S4R Stereoisomer of the Potent Aldose Reductase Cyclic Imide Inhibitor Fidarestat (2S4S) in the 15 K Crystal Structure of the Ternary Complex Refined at 0.78 Å Resolution : Implications for the Inhibition Mechanism
003293	E. A. Gould [France, Royaume-Uni] ; T. Solomon [Royaume-Uni] ; J. S. Mackeuzie [Australie]	Does antiviral therapy have a role in the control of Japanese encephalitis?
004D37	Jason S. Carroll [Australie] ; Danielle K. Lynch [Australie] ; Alexander Swarbrick [Australie] ; Jack-Michel Renoir [France] ; Boris Sarcevic [Australie] ; Roger J. Daly [Australie] ; Elizabeth A. Musgrove [Australie] ; Robert L. Sutherland [Australie]	p27Kip1 induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells
004E31	Ego Seeman [Australie]	Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis
004E68	Jean-Marie Boeynaems [Belgique] ; Francoise Wilkin [Belgique] ; Frédéric Marteau [Belgique] ; Xavier Duhant [Belgique] ; Pierre Savi [France] ; Nathalie Suarez Gonzalez [Belgique] ; Bernard Robaye [Belgique] ; Didier Communi [Belgique]	P2Y receptors: New subtypes, new functions
005258	Edmond Ekué Creppy [France] ; Adama Traore [France] ; Isabelle Baudrimont [France] ; Marta Cascante [Espagne] ; Maria-Rosaria Carratu [Italie]	Recent advances in the study of epigenetic effects induced by the phycotoxin okadaic acid
005300	Victor J. Dzau [États-Unis] ; Kenneth Bernstein [États-Unis] ; David Celermajer [Australie] ; Jerome Cohen [États-Unis] ; Björn Dahlöf [Suède] ; John Deanfield [Royaume-Uni] ; Javier Diez [Espagne] ; Helmut Drexler [Allemagne] ; Roberto Ferrari [Italie] ; Wiek Van Gilst [Pays-Bas] ; Lennart Hansson [Suède] ; Burkhard Hornig [Allemagne] ; Ahsan Husain [Australie] ; Colin Johnston [Australie] ; Harold Lazar [États-Unis] ; Eva Lonn [Canada] ; Thomas Lüscher [Suisse] ; John Mancini [Canada] ; Albert Mimran [France] ; Carl Pepine ; Ton Rabelink ; Willem Remme ; Luis Ruilope ; Marcel Ruzicka ; Heribert Schunkert ; Karl Swedber ; Thomas Unger ; Douglas Vaughan ; Michael Weber	Pathophysiologic and therapeutic importance of tissue ACE: A consensus report
005303	R. A. Roberts [France] ; S. Chevalier [France] ; S. C. Hasmall [Royaume-Uni] ; N. H. James [Royaume-Uni] ; S. C. Cosulich [Royaume-Uni] ; N. Macdonald [Royaume-Uni]	PPARα and the regulation of cell division and apoptosis
005444	Jerome Rossert [France] ; William M. Mcclellan [États-Unis] ; Simon D. Roger [Australie] ; Dierik L. Verbeelen [Belgique]	Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression?
005552	Robert E. Widdop [Australie] ; Khalid Matrougui [France] ; Bernard I. Levy [France] ; Daniel Henrion [France]	AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade
005843	C. Sonich-Mullin [Suisse] ; R. Fielder [Royaume-Uni] ; J. Wiltse [États-Unis] ; K. Baetcke [États-Unis] ; J. Dempsey [Australie] ; P. Fenner-Crisp [États-Unis] ; D. Grant ; M. Hartley [Australie] ; A. Knaap [Pays-Bas] ; D. Kroese [Pays-Bas] ; I. Mangelsdorf [Allemagne] ; E. Meek [Canada] ; J. M. Rice [France] ; M. Younes [Suisse]	IPCS conceptual framework for evaluating a mode of action for Chemical carcinogenesis
005C18	N. J. Russell [Royaume-Uni] ; M. Colley [Royaume-Uni] ; R. K. Simpson [Royaume-Uni] ; A. J. Trivett [Royaume-Uni] ; R. I. Evans [Royaume-Uni]	Mechanism of action of pulsed high electric field (PHEF) on the membranes of food-poisoning bacteria is an 'all-or-nothing' effect
005C54	Pascal Bousquet [France] ; Monique Dontenwill [France] ; Hugues Greney [France] ; Josiane Feldman [France]	Imidazoline receptors in cardiovascular and metabolic diseases
005E20	A. Lansiaux [France] ; A. Adams [Australie] ; W. A. Denny [Nouvelle-Zélande] ; C. Bailly [France]	Le DACA
005E48	V. Gerome [France] ; D. Lapraz [France] ; P. Iacconi [France] ; M. Benabdesselam [France] ; H. Prevost [France] ; A. Baumer [France]	Thermoluminescence mechanisms in rare earth doped CaSO4
005E50	G. Molnar [France, Hongrie] ; E. Papin [France] ; P. Grosseau [France] ; B. Guilhot [France] ; J. Borossay [Hongrie] ; M. Benabdesselam [France] ; P. Iacconi [France] ; D. Lapraz [France]	Thermally stimulated luminescence and exoelectron emission mechanism of the 430 K (D') dosimetric peak of α-Al2O3
005F37	M. Pabon [France] ; J. Selb [France] ; F. Candau [France] ; R. G. Gilbert [Australie]	Polymerization of acrylamide in solution and inverse emulsion : number molecular weight distribution with chain transfer agent
006005	P. Brooks [Australie] ; P. Emery [Royaume-Uni] ; J. F. Evans [États-Unis] ; H. Fenner [Suisse] ; C. J. Hawkey [Royaume-Uni] ; C. Patrono [Italie] ; J. Smolen [Autriche] ; F. Breedveld [Pays-Bas] ; R. Day [Australie] ; M. Dougados [France] ; E. W. Ehrich [États-Unis] ; J. Gijon-Banos [Espagne] ; T. K. Kvien [Norvège] ; M. H. Van Rijswijk [Pays-Bas] ; T. Warner [Royaume-Uni] ; H. Zeidler [Allemagne]	Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2
006016	JIN BO SU [France] ; F. Barbe [France] ; B. Crozatier [France] ; D. J. Campbell [Australie] ; L. Hittinger [France]	Increased bradykinin levels accompany the hemodynamic response to acute inhibition of angiotensin-converting enzyme in dogs with heart failure
006123	S. Guissi [France] ; P. Iacconi [France] ; R. Bindi [France] ; D. Lapraz [France]	Characterisation and modelling of the 450 K TSL peak of alpha alumina by the simultaneous analysis of TSL, TSC and TSEE
006710	S. Aubert [France] ; R. Bligny [France] ; D. A. Day [Australie] ; J. Whelan [Australie] ; R. Douce [France]	Induction of alternative oxidase synthesis by herbicides inhibiting branched-chain amino acid synthesis
006760	J. L. Smith [Australie] ; C. Lutton [France]	Determination of hepatic acyl-coenzyme A-cholesterol acyltransferase activity in LPN hamsters : A model for cholesterol gallstone formation
006965	L. P. Rivory [Australie] ; M. R. Bowles [Australie] ; J. Robert [France] ; S. M. Pond [Australie]	Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase
006B14	G. A. Head [Australie]	Baroreflexes and cardiovascular regulation in hypertension
006C18	C. J. Ormandy [Australie] ; C. S. L. Lee [Australie] ; P. A. Kelly [France] ; R. L. Sutherland [Australie]	Regulation of prolactin receptor expression by the tumour promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate in human breast cancer cells

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Mécanisme action And NotJ. I. Fletcher

List of bibliographic references